Press Releases

Press Releases

May 26, 2020
SAN DIEGO , May 26, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced that Ron Rocca , President and Chief Executive Officer of Exagen , will present at the William Blair
May 11, 2020
AVISE® Testing Volumes Increase with Retention Rate of 99% SAN DIEGO , May 11, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today reported financial results for the quarter ended
April 27, 2020
SAN DIEGO , April 27, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention, today
March 25, 2020
AVISE® Testing Revenue Drives 24% Revenue Growth SAN DIEGO , March 25, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis
Displaying 1 - 10 of 11